CEU sweeps 7 top spots in October 2025 Optometrists Licensure Exam

ALPHARETTA, Ga.—Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company developing therapies for the back of the eye through the suprachoroidal space (SCS), announced that it has filed for voluntary Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. As part of this process, Clearside said it intends to seek authorization for a Section 363 auction and sa